Business Assurance
5th Floor
Information Compliance
James Clerk Maxwell Building
57 Waterloo Road
London
SE1 8WA
Tel: 020 7848 7816
Email: xxxxxxxxxxxxxxx@xxx.xx.xx
Sarai Keestra
By email only to:
xxxxxxxxxxxxxxxxxxxxxxx@xxxxxxxxxxxxxx.xxx
17 December 2020
Dear Sarai Keestra
Request for information under the Freedom of Information Act 2000 (“the Act”)
Further to your recent request for information held by King’s College London, I am
writing to confirm that the requested information is not held by the university.
Your request
We received your information request on 19 November 2020 and have treated it as
a request for information made under section 1(1) of the Act.
You requested the following information:
START FOI request:
Q1. Can you release your internal strategy regarding licensing and patenting of COVID-19 related
health technologies?
Q2. Does the institution have a formal policy on licensing and patenting of COVID-19 related
technologies? If yes, please provide a link or PDF to the relevant policy document.
Q3. Has the university considered updating their strategy regarding the licensing and patenting of
health technologies since the start of the pandemic?
Q4. Please provide an Excel spreadsheet with headings as displayed below with all the COVID-19
related health technologies LICENSED by the university AND specify which countries they were
licensed in AND specify whether they are exclusive or non-exclusive licenses.
Health Technology Licensed | Country of Licensing | Type of License (Exclusive or Non-
Exclusive
Q5. Please provide a list of patents granted to your organization for any COVID-19 related health
technologies listed by patent family, indicating countries/regions in which the patent has been
granted.
Q6. Does the institution have any plans on signing up to the Open-COVID pledge
(https://eur03.safelinks.protection.outlook.com/?url=https%3A%2F%2Fopencovidpledge.org%
2F&data=04%7C01%7Cinfo-
compliance%40kcl.ac.uk%7C917dd5d348674567030c08d88c06230d%7C8370cf1416f34c16
b83c724071654356%7C0%7C0%7C637413305269433594%7CUnknown%7CTWFpbGZ
sb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0
%3D%7C1000&sdata=hP9sMZJnkaeTZb1Dm6J877a62KrxFkUqtnGCNR%2F86mc
%3D&reserved=0) or any similar initiative that seeks to minimise intellectual property
rights barriers during the COVID-19 pandemic? If yes, please specify.
Q7. Is the institution considering the licensing of COVID-19 related health technologies to the
Covid Technology Access Pool (C-TAP) or the Medicines Patent Pool (MPP) during the
pandemic? If yes, please specify.
Our response
Q1. Can you release your internal strategy regarding licensing and patenting of COVID-19
related health technologies?
Information not held.
Q2. Does the institution have a formal policy on licensing and patenting of COVID-19
related technologies? If yes, please provide a link or PDF to the relevant policy document.
There is no specific formal policy on licensing and patenting of COVID-19 related
technologies. The overarching policy (the Intellectual Property, Commercial Exploitation
and Financial Benefit, Code of Practice) can be found here:
https://www.kcl.ac.uk/governancezone/research/intellectual-property-commercial-
exploitation-and-financial-benefit
Q3. Has the university considered updating their strategy regarding the licensing and
patenting of health technologies since the start of the pandemic?
No
Q4. Please provide an Excel spreadsheet with headings as displayed below with all the
COVID-19 related health technologies LICENSED by the university AND specify which
countries they were licensed in AND specify whether they are exclusive or non-exclusive
licenses.
Health Technology Licensed | Country of Licensing | Type of License (Exclusive or Non-
Exclusive)
As yet, KCL have not licensed any Covid related technologies.
Q5. Please provide a list of patents granted to your organization for any COVID-19 related
health technologies listed by patent family, indicating countries/regions in which the patent
has been granted.
Zero
Q6. Does the institution have any plans on signing up to the Open-COVID pledge
(https://eur03.safelinks.protection.outlook.com/?url=https%3A%2F%2Fopencovidpledge.
org%2F&data=04%7C01%7Cinfo-
compliance%40kcl.ac.uk%7C917dd5d348674567030c08d88c06230d%7C8370cf1416f34c16
b83c724071654356%7C0%7C0%7C637413305269433594%7CUnknown%7CTWFpbGZsb
3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0
%3D%7C1000&sdata=hP9sMZJnkaeTZb1Dm6J877a62KrxFkUqtnGCNR%2F86mc
%3D&reserved=0) or any similar initiative that seeks to minimise intellectual property
rights barriers during the COVID-19 pandemic? If yes, please specify.
Review is ongoing.
Q7. Is the institution considering the licensing of COVID-19 related health technologies to
the Covid Technology Access Pool (C-TAP) or the Medicines Patent Pool (MPP) during
the pandemic? If yes, please specify.
No
This completes the university’s response to your information request.
Your right to complain
If you are unhappy with the service you have received in relation to your
information request or feel that it has not been properly handled you have the right
to complain or request a review of our decision by contacting the Assistant Director
of Business Assurance (Information Compliance) within 60 days of the date of this
letter.
Further information about our internal complaints procedure is available at the link
below:
http://www.kcl.ac.uk/college/policyzone/assets/files/governance_and_legal/Freed
om_of_Information_Policy_updated_Oct_%202011.pdf In the event that you are not content with the outcome of your complaint you may
apply to the Information Commissioner for a decision. Generally, the Information
Commissioner cannot make a decision unless you have exhausted the internal
complaints procedure provided by King’s College London.
The Information Commissioner can be contacted at the following address:
The Information Commissioner’s Office
Wycliffe House
Water Lane
Wilmslow
Cheshire
SK9 5AF
Yours sincerely
Olenka Cogias
Information Compliance